Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...
Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., and Cipla Ltd. share prices dragged the NSE Nifty Pharma index ...
Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...
"Roche has filed an appeal against the Hon. Delhi High Court order and the matter is subjudice in the appeal court," Roche ...
Roche had appealed against a single judge order of March 24 that had refused to stop Natco Pharma from manufacturing a generic version of Risdiplam ...
The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...
Explore more
Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.
In what could be promising news for patients battling spinal muscular atrophy (SMA), the Delhi High Court has refused to ...
The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.
Shares of Indian pharmaceutical firms rose 3%-13% after Trump did not specify reciprocal tariffs for the sector. The ...
Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...
It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results